A Study of REOLYSIN® in Combination With Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this Phase 2 study is to investigate whether intravenous administration of
REOLYSIN therapeutic reovirus in combination with gemcitabine is effective and safe in the
treatment of patients with advanced pancreatic cancer.